Adherence to Risk Evaluation and Mitigation Strategies (REMS) Requirements for Monthly Testing of Liver Function
Drugs in Context - United Kingdom
doi 10.7573/dic.212272
Full Text
Open PDFAbstract
Available in full text
Date
February 10, 2015
Authors
Publisher
BioExcel